Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression.

In addition to promoting tumor progression and metastasis by enhancing angiogenesis and invasion, myeloid-derived suppressor cells (MDSC) and tumor-associated macrophage (TAM) also inhibit antitumor T-cell functions and limit the efficacy of immunotherapeutic interventions. Despite the importance of these leukocyte populations, a simple method for their specific depletion has not been developed. In this study, we generated an RNA aptamer that blocks the murine or human IL-4 receptor-α (IL4Rα or CD124) that is critical for MDSC suppression function. In tumor-bearing mice, this anti-IL4Rα aptamer preferentially targeted MDSCs and TAM and unexpectedly promoted their elimination, an effect that was associated with an increased number of tumor-infiltrating T cells and a reduction in tumor growth. Mechanistic investigations of aptamer-triggered apoptosis in MDSCs confirmed the importance of IL4Ra-STAT6 pathway activation in MDSC survival. Our findings define a straightforward strategy to deplete MDSCs and TAMs in vivo, and they strengthen the concept that IL4Rα signaling is pivotal for MDSC survival. More broadly, these findings suggest therapeutic strategies based on IL4Rα signaling blockades to arrest an important cellular mechanism of tumoral immune escape mediated by MDSCs and TAM in cancer.

[1]  J. Califano,et al.  Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function , 2006, The Journal of experimental medicine.

[2]  B. Fingleton,et al.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.

[3]  F. Finkelman,et al.  Untangling the Complex Web of IL-4– and IL-13–Mediated Signaling Pathways , 2008, Science Signaling.

[4]  M. Karin,et al.  The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 , 2004, Nature.

[5]  M. Taura,et al.  TLR3 induction by anticancer drugs potentiates poly I:C‐induced tumor cell apoptosis , 2010, Cancer science.

[6]  K. Node,et al.  STAT6 Mediates Apoptosis of Human Coronary Arterial Endothelial Cells by Interleukin-13 , 2008, Hypertension Research.

[7]  T. Fitzwater,et al.  A SELEX primer. , 1996, Methods in enzymology.

[8]  G. Barber,et al.  PKR, apoptosis and cancer. , 1999, The international journal of biochemistry & cell biology.

[9]  S. Ugel,et al.  Therapeutic targeting of myeloid-derived suppressor cells. , 2009, Current opinion in pharmacology.

[10]  R. Ronca,et al.  Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. , 2000, Blood.

[11]  M. Hansmann,et al.  STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line , 2009, Leukemia.

[12]  D. Weissman,et al.  mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.

[13]  H. Giladi,et al.  TLR3 signaling in a hepatoma cell line is skewed towards apoptosis , 2007, Journal of cellular biochemistry.

[14]  S. Lebecque,et al.  TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells1 , 2006, The Journal of Immunology.

[15]  S. Biswas,et al.  Characterization of the nature of granulocytic myeloid‐derived suppressor cells in tumor‐bearing mice , 2012, Journal of leukocyte biology.

[16]  H. Young,et al.  Immortalized Myeloid Suppressor Cells Trigger Apoptosis in Antigen-Activated T Lymphocytes1 , 2000, The Journal of Immunology.

[17]  A. Keefe,et al.  SELEX with modified nucleotides. , 2008, Current opinion in chemical biology.

[18]  J. Berzofsky,et al.  Role of IL-13 in regulation of anti-tumor immunity and tumor growth , 2004, Cancer Immunology, Immunotherapy.

[19]  G. Mayer.  The chemical biology of aptamers. , 2009, Angewandte Chemie.

[20]  S. Mocellin,et al.  IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1 , 2009, The Journal of Immunology.

[21]  Maria R. Gumina,et al.  Cutting Edge: IL-4-Mediated Protection of Primary B Lymphocytes from Apoptosis via Stat6-Dependent Regulation of Glycolytic Metabolism1 , 2007, The Journal of Immunology.

[22]  P. Giangrande,et al.  Therapeutic applications of DNA and RNA aptamers. , 2009, Oligonucleotides.

[23]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[24]  Sudhir Srivastava,et al.  Posttranslational Protein Modifications , 2006, Molecular & Cellular Proteomics.

[25]  Jay A. Berzofsky,et al.  NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway , 2000, Nature Immunology.

[26]  Takashi Tanaka,et al.  The biology of Stat4 and Stat6 , 2000, Oncogene.

[27]  C. Alam,et al.  Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes , 2011, European journal of immunology.

[28]  P. Bevilacqua,et al.  Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure‐specific manner , 2008, RNA.

[29]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[30]  L. Coussens,et al.  MMP9 potentiates pulmonary metastasis formation. , 2002, Cancer cell.

[31]  B. Ma,et al.  ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. , 2005, The Journal of clinical investigation.

[32]  R. Ronca,et al.  Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. , 2000, Blood.

[33]  D. Green,et al.  Apoptosis and cancer. , 1994, Important advances in oncology.

[34]  D. Friend,et al.  Monoclonal antibodies block murine IL-4 receptor function. , 1990, Journal of immunology.

[35]  Rong-cheng Luo,et al.  Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells , 2011, Cell biology international.

[36]  M. Colombo,et al.  IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice1 , 2003, The Journal of Immunology.

[37]  Paolo Serafini,et al.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.

[38]  D. Togninalli,et al.  IL-4 and IL-13, But Not IL-10, Protect Human Synoviocytes from Apoptosis1 , 2001, The Journal of Immunology.

[39]  S. Bicciato,et al.  Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. , 2010, Immunity.

[40]  B. Sullenger,et al.  Gene therapy progress and prospects: RNA aptamers , 2007, Gene Therapy.

[41]  J. Berzofsky,et al.  Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance , 2003, The Journal of Experimental Medicine.

[42]  I. Borrello,et al.  Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. , 2008, Cancer research.

[43]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[44]  G. Peters,et al.  Phosphorylation of Specific Serine Residues in the PKR Activation Domain of PACT Is Essential for Its Ability to Mediate Apoptosis* , 2006, Journal of Biological Chemistry.

[45]  W. Paul,et al.  Interleukin 4 receptor: signaling mechanisms. , 1994, Immunology today.

[46]  P. Sinha,et al.  Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. , 2005, Cancer research.

[47]  A. Theocharis,et al.  Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression. , 2006, Advances in pharmacology.

[48]  I. Dusanter-Fourt,et al.  Interleukin‐4 induces human hepatocyte apoptosis through a Fas‐independent pathway , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.